BioSpace News Archive

Milliman, Inc., a premier global consulting and actuarial firm, today released the 2019 Milliman Medical Index (MMI), which measures healthcare costs for individuals and families receiving coverage from an employer-sponsored preferred provider plan (PPO)

GI Alliance, the nation’s largest independent gastroenterology services organization, announced a partnership with Illinois Gastroenterology Group.

Nurses represented by the Massachusetts Nurses Association will present a $3,000 check to the Martha’s Vineyard Bus Drivers who have been on strike since June 28 to support struggling drivers and their families, and to demonstrate solidarity with workers seeking livable wages, job security and affordable healthcare.

Turning Point of Tampa is proud to announce our Medical Director, Hardeep Singh, MD, has been named in Tampa Magazine’s Top Doctors 2019.

The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, UK by Professor Adrian Banning, the principal investigator of the study.

Key findings from a Humana Inc. (NYSE: HUM) study, published in the June 2019 issue of Journal of Managed Care & Specialty Pharmacy (JMCP), highlight the differences in effectiveness between medication therapy management (MTM) services and the untapped potential for certain interventions.

September conference led by Colorado BioScience Association to provide companies from across the region new opportunities for capital access

Resonea, Inc., (“Resonea” or the “Company”) a technology company founded to create a new standard for understanding sleep and breathing and their long-term impact on wellness, performance, and quality of life, announced that they obtained 510(k) clearance from the US Food and Drug Administration (FDA) on July 14, 2019 for their DROWZLE® Sleep Apnea Pre-screening Device.

Virginia Bio, the statewide non-profit trade association for the life science industry, announces that John L. Newby II is named CEO, effective August 5, 2019.

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing and drug delivery solutions, today announced that its Unidose Powder System was recently approved by the U.S. Food and Drug Administration (FDA) for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people with diabetes.